Anik

[GGal]

Bought ANIK. Expecting their revenues from the knee osteoarthritis product to grow.

GA

[GGal]

Anika Therapeutics (ANIK - commentary - Cramer's Take - Rating) advanced 24.6% to $14.40 following word that it received an approvable letter from the Food and Drug Administration for its cosmetic tissue augmentation product. CTA is an injectable soft-tissue filler for facial wrinkles, scar remediation and lip augmentation. The final approval is expected by the end of the year

[mlk_man]

GG, you don't need that!!!!!!!!!!!! Eat more peaches!! :)

[GGal]

Smooch me in reverse, "Mr. Dirty Mouth"......(stolen from Boston Legal)!